Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence - a meeting report.

de Moerlooze L, Allen A, Bartalesi I, Cavaleri M, Davenport MP, Gessner BD, Gomes B, Hayford K, Izu A, Izurieta HS, Jenkins VA, Kastner R, Krause P, Nealon J, Oostvogels L, Palmu AA, Read RC, Saenz C, Smith DK, Tuboi S, Vandendriessche F, Baay M, Craig D, Neels P, Bollaert K

Open source

DOI: 10.1016/j.biologicals.2026.101886
Published: 2026 Aug
Container: Biologicals : journal of the International Association of Biological Standardization
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.biologicals.2026.101886,
  title = {Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence - a meeting report.},
  author = {de Moerlooze L and Allen A and Bartalesi I and Cavaleri M and Davenport MP and Gessner BD and Gomes B and Hayford K and Izu A and Izurieta HS and Jenkins VA and Kastner R and Krause P and Nealon J and Oostvogels L and Palmu AA and Read RC and Saenz C and Smith DK and Tuboi S and Vandendriessche F and Baay M and Craig D and Neels P and Bollaert K},
  year = {2026},
  journal = {Biologicals : journal of the International Association of Biological Standardization},
  doi = {10.1016/j.biologicals.2026.101886},
  url = {https://doi.org/10.1016/j.biologicals.2026.101886}
}

RIS

TY  - JOUR
TI  - Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence - a meeting report.
AU  - de Moerlooze L
AU  - Allen A
AU  - Bartalesi I
AU  - Cavaleri M
AU  - Davenport MP
AU  - Gessner BD
AU  - Gomes B
AU  - Hayford K
AU  - Izu A
AU  - Izurieta HS
AU  - Jenkins VA
AU  - Kastner R
AU  - Krause P
AU  - Nealon J
AU  - Oostvogels L
AU  - Palmu AA
AU  - Read RC
AU  - Saenz C
AU  - Smith DK
AU  - Tuboi S
AU  - Vandendriessche F
AU  - Baay M
AU  - Craig D
AU  - Neels P
AU  - Bollaert K
PY  - 2026
JO  - Biologicals : journal of the International Association of Biological Standardization
DO  - 10.1016/j.biologicals.2026.101886
UR  - https://doi.org/10.1016/j.biologicals.2026.101886
ER  -

APA

L, D. M., A, A., I, B., M, C., MP, D., BD, G., B, G., K, H., A, I., HS, I., VA, J., R, K., P, K., J, N., L, O., AA, P., RC, R., C, S., DK, S., S, T., F, V., M, B., D, C., P, N., & K, B. (2026). Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence - a meeting report.. Biologicals : journal of the International Association of Biological Standardization. https://doi.org/10.1016/j.biologicals.2026.101886

Source records

pubmed · retrieved 2026-09-25T22:57:23.367Z
europe-pmc · retrieved 2026-09-25T22:57:23.378Z